Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 76282-664

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 76282-664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)
This is not a readable text; hence the description cannot be generated.*
FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

Figure 3 (Sevelamer Carbonate Tabs Fig03)
This appears to be a graph or chart showing the reduction in serum phosphorus in patients taking Sevelamer Hydrochloride compared to an active control. The x-axis shows the reduction in mg/dL over a timeline of 2, 4, and 6 units. The y-axis indicates the percentage of patients experiencing improvement or worsening of their phosphorus levels. There is also some text labeled "Percentage of Patients" with numbers and letters that do not appear to be part of the graph.*
FDA Label Image

Sevelamer Carbonate Tabs Fig04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.